Athira Pharma Inc
ATHAAthira Pharma is a clinical stage American therapeutics company developing regenerative therapies for neurological diseases such as Alzheimer's disease and Parkinson's disease. The company's main product is in very early human studies for Alzheimer's disease as of 2019.The company was founded in 201 …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Athira Pharma Inc
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/2/2025 | Sell | Worthington, Mark | General Counsel and CCO | $0.6 | $4,782 |
| 1/2/2025 | Sell | Renninger, Robert | VP of Finance | $0.6 | $1,619 |
| 1/2/2025 | Sell | Church, Kevin | CHIEF SCIENTIFIC OFFICER | $0.6 | $4,782 |
| 1/2/2025 | Sell | Litton, Mark James | President and CEO | $0.6 | $14,108 |
| 1/2/2025 | Sell | San, Martin Javier | CHIEF MEDICAL OFFICER | $0.6 | $6,083 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)